Stories

As a senior principal developer for the brand-new Process Innovation Through Automation Laboratory, Brian Dukek helps labs throughout the Department of Laboratory Medicine and Pathology evaluate new automation tools and streamline automation workflows.

This week's Research Roundup features: Laboratory and metabolic investigations.

Today's Highlights Include: Ozempic running low for diabetes patients as weight-loss use surges, and Rochester public schools gets $1.9M for mental health scholarships.

As a director of operations for Mayo Clinic Laboratories, Callie Bishop helps meet the needs of Mayo Clinic Laboratories clients both virtually and onsite in the field.

Mayo Clinic Laboratories expanded movement disorders panel better identifies autoimmune conditions. Four recently identified biomarkers — septin-5, septin-7, neurochondrin, and adaptor protein-3B2 — have been added to the panel, and all four have been shown to respond to immunotherapy.

After what looked like a blemish turned out to be angiosarcoma, a rare, life-threatening cancer of the blood vessels, Alison O'Neill was put on an aggressive treatment plan and regenerative approach to healing made possible by the pathologist who first diagnosed her cancer.

As a national accounts executive for Mayo Clinic Laboratories, Paul Schneider helps to improve and advance diagnostic patient care by bringing Mayo Clinic Laboratories testing to many of the nation’s top health care systems.

This week's research roundup features: Emergence of restless legs syndrome during opioid discontinuation

This weeks research roundup features: Automated scoring of total inflammation in renal allograft biopsies

As a national accounts executive for Mayo Clinic Laboratories, Kimberly Knight helps clients see and understand the importance of laboratory testing and how partnering with Mayo Clinic Laboratories on that testing can help them and their patients.

This week's research roundup features: Exploring gene expression profiles in primary central nervous system vasculitis

Mayo Clinic Laboratories is committed to innovation that provides the right test at the right time for the right patients. That effort always starts with identifying gaps in patient care. Filling those gaps sometimes involves not developing new tests but finding ways to make existing tests more efficient and easier for patients.

This week's research roundup features: Drug testing in support of the diagnosis of neonatal abstinence syndrome: The current situation